智通财经APP讯，先瑞达医疗-B(06669)发布公告，于2025年8月13日，集团收到北京市药品监督管理局对微导丝的注册批准。微导丝适用于常规外周血管内使用，用于引导和放置诊断或治疗用器械。本产品提供0.014”和0.018”两种外径规格，其头端10 厘米柔软段采用渐细式芯丝设计，外套激光雕刻海波管，这样的结构能够保证卓越的输送和扭控性能，助力医生应对复杂血管挑战。公司将适时在中国开展营销活动。
智通财经APP讯，先瑞达医疗-B(06669)发布公告，于2025年8月13日，集团收到北京市药品监督管理局对微导丝的注册批准。微导丝适用于常规外周血管内使用，用于引导和放置诊断或治疗用器械。本产品提供0.014”和0.018”两种外径规格，其头端10 厘米柔软段采用渐细式芯丝设计，外套激光雕刻海波管，这样的结构能够保证卓越的输送和扭控性能，助力医生应对复杂血管挑战。公司将适时在中国开展营销活动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.